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Abstract 
Purpose:  The purpose of this quality improvement (QI) project was to assess provider (MD and 
Neonatal Nurse Practitioners (NNP)) comfort and confidence with Near-infrared Spectroscopy 
(NIRS) monitoring on Newborn Intensive Care Unit (NICU) patients when provided with an 
educational teaching session. 
Background and Significance:  NIRS data can be used in conjunction with standard vital sign 
monitoring to help clinicians understand blood flow and metabolic demands of organ systems, 
particularly cerebral, renal, and mesenteric blood flow patterns.  A NICU unit in the 
northwestern US adopted NIRS use on their patients in 2008, however, NIRS monitoring usage 
decreased over the past 5 years, citing a lack of continued education and comfort interpreting and 
managing NIRS monitored patients.  One patient was monitored with NIRS in the year prior to 
the QI project. 
Methods: A 5 point Likert-Type survey was designed to examine provider comfort and 
confidence using and interpreting NIRS on NICU patients.  No Croanbach’s alpha value exists 
for the survey as it was purposefully designed for the QI project.  An educational presentation on 
the use and interpretation of NIRS on NICU patients was created and delivered during a formal 
provider staff meeting.  Pre and Post education surveys were distributed electronically to 
participants and were presented 1 week prior to educational session and 1 month after 
educational session.  IBM SPSS version 23 was used for descriptive statistics, paired t tests, and 
Wilcoxon test. Significance set to p<0.05. 
Results: In total, 18 providers (N=18) were surveyed, and 13 paired survey results (n=13) were 
received (8 MD and 5 NNP).  Paired-samples t tests were calculated to compare the mean total 
score (TS) for pre/post comfort and pre/post confidence.  This was a significant improvement for 
both comfort (t(11) = -3.13, p=0.010) and confidence (t(11) = -3.37, p=0.006).  Wilcoxon test 
showed a significant increase in the times a provider managed a patient with NIRS (z=-2.762, 
p=0.006).  The number NIRS monitored patients increased from one in the previous year to 15 
patients in the 5 months of data tracking, a clinically significant increase. 
Conclusions: Providing educational session on previously utilized clinical applications can 
improve providers comfort and confidence and influence their usage in clinical practice.  Future 
continuing education sessions could be designed for different clinical applications in order to 
keep clinicians abreast of the current evidenced based applications of advanced clinical monitors.  
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Neonatal intensive care units help to provide care and support to infants born both prematurely 
and those with illness or infection.  Complex vital sign monitoring is required to maintain 
homeostasis and indicate times for needed interventions.  Routine vital sign monitors may be 
inadequate at capturing end organ demands in vulnerable neonatal populations.  Current 
noninvasive blood pressure monitoring gives a momentary picture of hemodynamic stability and 
does  not provide continuous moment to moment feedback that a dynamic critically ill neonate 
can require (Greison, Leung, & Wolf, 2011).  Near-infrared spectroscopy monitoring may 
provide practitioners with additional information to better care for at risk neonatal populations. 
Problem Statement 
 Preterm and vulnerable term infants in neonatal intensive care units (NICU) are at risk for 
cerebral, renal, and mesenteric hypotension making them susceptible to intraventricular 
hemorrhage (IVH), feeding intolerance, necrotizing entrocolitis (NEC) and acute renal failure.  
Current monitoring of standard vital signs may not be capable of accurately identifying this end 
organ hypoperfusion.  Regional saturation monitors, also known as near-infrared spectroscopy 
monitors (NIRS), are currently available within NICUs to monitor regional saturations across 
time (Sood, McLaughlin, & Cortez, 2015), however, the medical team in a northwestern city 
cites a lack of education  related to the use and benefits of the monitors preventing them from 
using them on high-risk NICU patients.  Centers across the nation caring for similar acuity 
infants utilize NIRS monitors on patient populations that are at higher risk for systemic 
hypotenison/hypoxia such as infants with congenital cardiac defects (Chock, Rose, Mante, & 
Punn, 2016, & Gillam-Krakauer et al., 2013).  The SafeBoosC clinical trials established 
treatment guidelines for the use of NIRS in NICU patients for monitoring cerebral tissue 
oxygenation (Pellicer et al., 2013) and have been able to show reductions in cerebral oxygen debt 
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associated with hypoperfusion (Hyttel-Sorensen, et al., 2013 ).  Though exact numbers of infants 
who experience hypotension is not known given our current monitoring systems, data regarding 
infants who require blood pressure medications has been researched.  Laughon et al. (2010) 
examined extremely low birth weight infants showed that 90% of 23 week infants and 89% of 27 
week infants required some form of blood pressure supportive measures within the first 24 hrs of 
life.  Review of the electronic medical record at the northwestern NICU showed there have been 
zero prescribed uses of the NIRS monitor for the previous year.   
Purpose and Rationale 
 Currently, a level 4 non-complex cardiac care, non-ECMO NICU in the northwestern 
United States has NIRS monitors available, however, does not use them because of lack of 
practitioner education about the benefits and data output generated when monitoring cerebral, 
renal, and mesenteric regional saturations.  The NICU site cares for infants from 22 weeks 
through post term and utilizes multiple monitors beyond standard vital sign monitoring including 
amplitude electroencephalogram and transcutaneous carbon dioxide monitoring.  Sood, 
McLaughlin, and Cortex (2015) cited ten different NICU patient groups that use NIRS 
monitoring including neonates with complex heart disease, preterm infants at risk for patient 
ductus arterosis (PDA), and infants at high risk for IVH.  Investigating the use of NIRS in the 
NICU may provide additional data to better support infants at risk for systemic end organ hypo 
perfusion and guide earlier interventions.   
Background/Significance 
 There are groups of preterm and term infants that are at high risk for shunting blood flow 
preferentially causing end organ hypo perfusion and hypoxia.  The highest risk populations 
include preterm (infants born less than 35 weeks), infants with cardiac defects, infants who have 
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experienced intrauterine growth restriction (IUGR) and infants who have experienced hypoxic 
ischemic events (HIE) (Blackburn, 2013; Gleason & Devaskar, 2012; Lin, Hagan, Fenoglio, 
Grant, & Franceschini, 2016).  These groups of infants could benefit from advanced vital sign 
monitoring beyond the standard vital signs monitoring done on routine patients in neonatal 
intensive care units (NICU).  Current vital sign monitoring includes heart rate, respiratory rate, 
oxygen saturation, temperature, blood pressure and pain.  Near-infrared spectroscopy offers 
additional vital sign monitoring by providing regional oxygen saturation data thus giving 
information on both the blood flow and the metabolic needs of the end organ systems.  Liu, 
Chalak, and Lu (2014) cited that not being able to meet an end organs metabolic demands or a 
states of end organ hypotension places infants at higher risk for IVH and long-term neurologic 
deficits.  Bozzetti et al. (2016) utilized NIRS to show that IUGR infants continued to shunt blood 
flow preferentially to their brain over their GI tracts even after birth, a phenomenon not visible to 
practitioners utilizing routine vital sign monitoring.   
 In current NICU practice, hypotension is defined as a mean blood pressure less than the 
infant's gestational age in weeks.  This is measured on a peripheral limb with a cuff or centrally 
with an invasive blood pressure monitoring device such as an umbilical artery catheter.  The 
presence however of a hemodynamically significant patient ductus arteriosus (hsPDA) has the 
potential to cause decreased the mean blood pressure downstream causing the blood pressure at 
the level of the kidney to be less than the measured upper limb cuff blood pressure.  Blood flow 
to the end organ systems such as the kidneys cannot be measured by this technique and current 
practice is to assume that if an infant is making urine then there is adequate blood flow to the 
kidneys.  Similarly, there is no direct measure of cerebral blood flow or cerebral oxygen 
requirements.  Preterm infants are at high risk for intracranial bleeding due to an inability to 
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autoregulate their cerebral blood pressure as well as the presence of a highly vascular structure 
known as the germinal matrix (Gleason & Devaskar, 2012).  The germinal matrix exists in 
preterm infants and is often the site for most intracranial bleeds where as in term infants this 
structure has matured and is much less likely to be at risk for bleeding (Blackburn, 2013).  
 Near-infrared spectroscopy monitoring has been used in NICU patients as far back as 
1985 (Greison, Leung, &Wolf, 2011), however, not until recent SafeBoosC Phase II clinical 
trials (Riera, et al., 2016) and 2-center randomized controlled pilot study (Pichler et al, 2013) 
were reference ranges established for infants.  NIRS monitors provide real time end organ 
saturation data allowing practitioners the ability to visualize the impact of interventions on end 
organ blood flow (Greison, Leung, & Wolf, 2011).  Regional saturation information is 
determined by examining the difference between the arterial and venous oxygenated hemoglobin 
molecules and the end organ uptake of oxygen also known as metabolic demand (Liao & Culver, 
2014).  There has been a surge in publications in the last five years pertaining to the use of NIRS 
monitoring in NICU patients to help better guide both the resuscitation of preterm infants and 
interventions to protect against end organ hypoprofusion including Pellicer, et al. (2013), Pichler, 
et al. (2015), and Plomgaard, et al. (2016).  Alderliestin et al. (2016) published NIRS reference 
ranges for both term and preterm infants for the first three days of life enhancing practitioners 
understanding of how the cerebral oxygen saturation changes overtime in infants.  Kenosi et al. 
(2015) provides an overview of current NIRS research and use in NICU patients as well as 
suggesting future research regarding cerebral monitoring during the birth process. 
Problem Statement 
 This inquiry has lead to the clinically relevant PICO question, "In Neonatologists and 
Neonatal Nurse Practitioners, does providing education on the use and interpretation of Near-
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Infrared Spectroscopy monitoring on Newborn Intensive Care Unit patients affect their comfort 
and confidence using and ordering NIRS and the frequency of ordering the intervention 
compared to no formal education"?  
Search Strategy 
 Searches were conducted utilizing Cumulative index of nursing and allied health 
literature (CINAHL), PubMed, and the Cochrane Library.  Keywords of NICU, Newborn, infant, 
neonate, NIRS, near infrared spectroscopy, INVOS, monitoring, intervention, and education 
were used.  Initial CINAHL results (Appendix A) for search terms Infant or neonate and INVOS 
or NIRS or near infrared spectroscopy produced 1,675 results and PubMed (Appendix B) 
provided 55 results.  Cochrane library (Appendix C) initial search for infant produced 40,087 
results and was further narrowed using infant and NIRS or INVOS to 47 results.  No initial 
limiters were placed on the search results and no publication data limit.  Further combining 
search terms together produced 46 results through CINHAL (Appendix A), 55 results through 
PubMed (Appendix B), and 47 results through Cochrane Library (Appendix C).  One hundred 
and forty eight studies were identified and duplicates were removed.  Elimination criteria were 
implemented including publication within the last 10 years, available in English, and full text 
available.   Thirty-nine studies were then selected for review.   
 Primary preference was given to studies of either systematic reviews or randomized 
controlled trials.  One systematic review and three randomized controlled trials are included in 
the evaluation table (Appendix D).  Multiple non-systematic reviews of the current use of NIRS 
in the NICU were excluded though they provided background to the current uses and 
implantation of NIRS protocols in neonatal care.  The table (Appendix D) discusses the purpose 
and significant findings of 10 of the 39 reviewed studies.  The findings help establish how NIRS 
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monitoring is currently utilized in NICU patients and additional research being done with NIRS 
monitoring. 
Critical Appraisal and Synthesis 
 Ten studies were included in this literature review; all studies were evaluated using the 
rapid clinical appraisal tool from Melnyk and Fine-Overhold (2015) and their results are 
presented in an evidence table for analysis (Appendix D).  Included are two randomized 
controlled trials (RCT), one extension of data gathered during an RCT, one systematic review 
(SR), one prospective observational trial (POT), one non-aprori retrospective study (NPRS), two 
observational cohort studies (OCS), one prospective observational study (POS), one case control 
(CS), and one prospective case-control study (PCCS).  The levels of evidence include one level 
one, three level two, three level three, two level four and one level six, based on Melnyk and  
Fine-Overhold (2015) classification of evidence, providing a range of study designs.  Sample 
sizes varied from 3 to 999 participants and the SR examined 229 studies.  The ten studies 
provided a good representation of current use of NIRS in NICU patients and provide reference 
curves for the use NIRS on both term and preterm infants.  The studies provide the clinical 
background for addressing the PICO question explored in this examination.  A synthesis table 
(Appendix E) was created to illustrate the pertinent findings noted in the evidence table 
(Appendix D).   
 All ten studies were published in the last five years and all completed within the NICU 
setting.  Most studies were published in Europe, with two studies being multicenter trials.  
Homogeneity was noted in the demographics across studies with participants being both term 
and preterm infants with similar ranging birth weights.  APGAR scores assigned to patients at 
both one and five minutes were homogenous across the sample. 
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 The study findings included establishing rScO2 reference plots for both term and preterm 
infants from birth through transition and birth through first 72 hrs of life, a reduction in overall 
oxygen debt (cerebral), the ability to monitor for hsPDA, and visualization of the physiologic 
response of the mesenteric artery velocity in relation to feeding.  Prior to rScO2 reference plots  
being created clinicians interpreted NIRS data from unpublished reference ranges that were 
established on well term infants.  Cerebral oxygen debt, defined as the time spent outside of 
expected rScO2 saturations ranges during newborn transition, was shown to be reduced when 
resuscitation team members were able to view the real time NIRS monitoring data.  The 
hemodynamic status of an infant's PDA was shown to be able to be monitored with NIRS by 
utilizing a ratio between simultaneously measured rScO2 and rSmO2 values.  Lastly, rSmO2 
monitoring was able to show the physiologic response feeding had on the blood flow to an 
infant's gastrointestinal tract by monitoring the regional saturation and ultrasound velocity of the 
mesenteric artery.   
 The primary variables measured included measurement of three different NIRS values, 
rScO2, rSrO2, and rSmO2, the time domain, and detection of hemodynamically significant PDA.  
Moderate homogeneity exits between the period analyzed across studies ranging from birth to 
transition through birth to 72 hrs.  All nine studies utilized INVOS monitors for data 
measurement making for consistent comparison across studies.  No validity or reliability was 
stated for the INVOS measurements. 
Conclusions about Evidence 
 Evaluation of the synthesis table (Appendix E) shows that NIRS monitoring provides 
actionable data for clinicians when used on a variety of NICU patients.  NIRS can be utilized to 
monitor infants during birth transition, prompting clinicians to add or remove respiratory support 
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in response to cerebral saturations.  This can help reduce oxygen debt, an important concept for 
preterm infants with reduced cerebral auto-regulation of blood flow and blood pressure.  
Reducing the oxygen debt has the potential to then reduce IVH rates leading to better overall 
neurologic outcomes though this potential has not yet been fully studied by utilizing the NIRS 
monitor.   
 NIRS provides clinicians the ability to monitor physiologic parameters including the 
status of an infant’s PDA, potentially saving the patient financially by reducing the frequency of 
screening echocardiograms.  The PDA status is monitored by measuring a ratio of the rScO2 and 
rSmO2, giving medical providers’ additional information on cerebral oxygen debt and abdominal 
blood flow patterns.   
 The creation of gestational age specific reference plots for expected rScO2 values over 
time provides guidance to both medical staff and nursing for managing patients and 
interventions.  The SafeBoosC clinical trial (Riera, et al., 2016) established intervention 
guidelines for saturations outside of the reference values and has been shown to reduce overall 
oxygen debt and improve outcomes. 
  Though these highlighted clinical applications do not directly answer the PICO question 
they provide the fundamental background for the current usefulness of NIRS in NICU patients.  
Providing this NIRS background data, in conjunction with education on NIRS management, to 
the medical team in the Northwestern NICU should assist in making a change in clinical practice 
and ordering of NIRS monitoring. 
Theoretical Framework 
Near-infrared spectroscopy monitoring is a measure of a physiologic response to 
changing conditions within the body, however, Kurt Lewin’s Change theory was chosen as a 
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conceptual framework to guide this project as the focus is on changing the behaviors of the 
participants.  For this project, the participants are the medical team in the Northwestern NICU 
and the behavior is the utilization of NIRS monitoring on their patients. 
  Change theory is a three-step process involving unfreezing, moving, and refreezing to 
change behaviors and three major concepts driving forces, restraining forces and equilibrium 
(Polt & Beck, 2015).  Lewin discussed driving forces that influence organizations towards 
change and restraining forces to remain the same, keeping the organization in a state of 
equilibrium (Polt & Beck, 2015 & Lewin’s Change theory, n.d.).  Unfreezing of a behavior must 
first take place in which a new solution is found, then the influencing forces must be addressed, 
before movement can happen on the behavior.  Refreezing takes place when the new behavior is 
integrated into practice creating a new state of equilibrium in the system.   
The current state of equilibrium in the Northwestern NICU is one of little to no use of 
NIRS on high risk neonates.  To shift this to the goal of increased utilization the staff will need to 
be willing to unfreeze, accept the education, and refreeze by integrating NIRS into their practice.  
Key stake holders have been identified and have assisted in creating buy-in from the rest of 
medical staff to overcome increase the driving force to moving.  An educational intervention is 
being proposed with a goal of decreasing the restraining forces that can negatively affect the 
movement.  Assessing the refreezing process and establish the use of NIRS in the NICU will be 
done by a pre-and post-educational session surveying to assess the providers change in comfort 
and behavior prescribing the use of NIRS.  
Evidence Based Practice Model 
 Rosswurm and Larrabee (1999) evidenced based practice (EBP) model was chosen to 
guide the implementation of the evidence.  The model (Appendix F) involves six steps from 
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exploring a clinical gap to maintenance of the intervention.  Rosswurm and Larrabee EBP model 
was chosen primarily for its focus on integration and maintenance of change beyond the initial 
change process.  Review of the Northwestern NICU's electronic medical record (EMR) shows no 
orders for the use of NIRS monitoring, even with three dedicated monitors available for NICU 
patients, showing the gap in clinical practice.  The lack of education was cited as the problem 
leading to the practice gap that linking the problem to the intervention laid out in step two of the 
EBP model.  Buy in from the medical team has been established, and best evidence was 
reviewed and synthesized (Appendix E) relating to the use of the NIRS in NICU patients.  Going 
forward education will be designed and presented to the medical staff and the bedside RNs on 
use and management of NIRS for at risk NICU patients.   
Purpose Statement 
 The purpose of this quality improvement (QI) project was to increase provider (doctors 
and neonatal nurse practitioners) comfort and confidence using, interpretering, and ordering 
near-infrared spectroscopy (NIRS) monitoring on neonatal intensive care (NICU) patients.  The 
providers will benefit from the project by gaining improved knowledge leading to potentially 
improved health outcomes for the patients in their care.  The goal of the project is to see an 
increase in the providers comfort and confidence and see an increase in the utilization of NIRS in 
the NICU. 
Methods 
 Intuitional review board (IRB) approval was applied for and granted from Arizona State 
University and the northwestern NICU hospital to conduct the QI project.  The QI project was 
conducted at a single NICU site that cares for infants from 22 weeks through post term with a 
wide range of children's specialty services.  The NICU has a max census of 64 patients and an 
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average daily census of 30-35 patients.  The NICU had adopted the use of NIRS ~10 years ago 
and the QI project required no financial budget as the NICU already owns the NIRS monitors to 
be utilized for patient monitoring. 
 Eighteen doctors and NNPs were recruited for the project.  The project design was an 
interventional education session with a pre and post intervention survey and usage tracking of 
clinical orders for a 3 month period, however, the tracking phase was extended to 5 months.  The 
primary investigator was the only team member supporting the project and was available to 
support the providers by phone and in person. 
 An educational session was designed and delivered to the providers by the primary 
investigator.  The session consisted of a PowerPoint, handouts, and question and answer period.  
The educational session was delivered during a medical staff meeting and the materials used 
were then distributed to the staff for review via their work emails. 
 A 5-point Likert-type survey was created and then distributed to the NICU providers 
using a Google form (Appendix F).  The survey contained consent to participate in the project, a 
unique reproducible identifier for the provider to fill out for pairing pre and post surveys, 
demographics questions (job role, years in role, years at northwestern NICU), and 13 questions 
on the use and interpretation of NIRS.  The same survey was used pre and post educational 
session to measure the change in the providers.  Two primary concepts were explored were 
comfort and confidence using, ordering, and interpreting NIRS data.   No Croanbach's alpha 
value exists for the survey as it was specifically designed to assess the providers comfort and 
confidence using NIRS.  No established survey tool was found specifically designed for the 
content examined in this QI project. 
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 Surveys were distributed to the participants through their work email accounts via a web 
link to the survey.  The primary investigator was the only person with access to the online survey 
results.  The results were then converted to an Excel spreadsheet and printed to be stored by the 
primary investigator.  No provider identifiers were collected beyond the unique reproducible 
identifier used to pair pre and post educational surveys in order to maintain participant 
anonymity and each participant provided their consent to participate in the project with each 
survey they filled out. 
 The pre survey was distributed 7 days prior to the educational session and responses were 
accepted until the day of the educational session.  The post survey was distributed to the 
participants one month after the educational session and responses were accepted for a 10 day 
period.   
 The one month period following the educational session was noted to have a lower than 
normal census in the NICU prompting the investigator to modify the original QI plan.  The lower 
than normal census period resulted in no NICU patients being considered for monitoring causing 
there to be no potenital change to be measured by some of the survey questions.  To account for 
this period of low census the tracking period was extended from 3 months to 5 months and an 
abbreviated survey was created to revaluate three survey questions.  The abbreviated survey was 
distributed 4 months after the educational session and responses were accepted for 2 weeks. 
 The survey results were validated and entered into IBM SSPS version 23 for analysis.  
Demographic data was analyzed with descriptive statistics.  NIRS frequency survey questions 
were analyzed using a Wilcoxon analysis.  The comfort and confidence concepts were analyzed 
using mean total score paired t tests.  The significance was set to p<0.05.   
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 The usage data tracked included the gestational age of the NICU patient at birth and at 
time of NIRS ordering, the sites monitored with NIRS, and the length of time the patient was 
monitored.  This information was gathered from the electronic medical record and was recorded 
in an Excel spreadsheet and printed to be stored by the primary investigator.  The pre 
intervention data was examined for the 1 year period before the project and the post intervention 
data was tracked for a 5 month period.  No patient identifiers were collected during the project in 
order to protect the identity of the patients monitored with NIRS. 
Outcomes 
 Eighteen NICU providers completed the initial pre survey (8 MD/10 NNP) and 13 
providers completed the post education survey (7 MD/8 NNP).  The samples were paired using a 
unique reproducible identifier made by the provider at the time the survey for a total of 13 paired 
surveys.  Additionally 16 providers completed the abbreviated surveys and those results were 
then paired to the pre educational survey results. 
 Descriptive statistics on the providers including their role in the NICU (MD or NNP), the 
years they have been in that role and the number of years they have been with the Northwestern 
NICU.  The 13 providers (61% MD/ 39% NNP) had worked in their role on average 11.25 years 
(sd=5.8) with a range of 0.1-20 years.  Significance for parametric and non-parametric statistics 
was set to p<0.05. 
 A Wilcoxon test examined the results of three survey questions; how frequently providers 
ordered NIRS, how frequently providers managed NIRS and how frequently providers managed 
NIRS ordered by another provider.  A significant difference was found in the results for the how 
frequently providers managed patients with NIRS with the result of (z= -2.762, p=0.006) 
between the pre intervention survey results and the abbreviated survey results given at 4 months.  
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Providers stated that they managed patients more frequently after the educational session with 
NIRS in place.  No significant difference was found the providers response to the frequency 
which they ordered NIRS (z=1.51, p=0.132) and how frequently they managed NIRS ordered by 
another provider (z=-1.01 , p=0.314).   
 Paired-samples t test was calculated to compare the mean total score for pre survey for 
both comfort and confidence to the mean total score post survey.  The pre education mean total 
score for comfort was 8.77 (sd=2.62) and the mean total score post education was 12.85 
(sd=4.52).  The pre education mean total score for confidence was 12.33 (sd= 4.54) and the mean 
total score post education was 16.42 (sd=5.38).  A significant increase was noted for both 
comfort (t(11)=-3.13, p=0.010) and confidence (t(11)=3.37, p=0.006) at one month after 
educational session. 
 The clinical use of NIRS in the NICU changed considerably from the 1 year prior to 
educational session with one patient monitored in that time and 15 patients monitored during the 
5 months of data tracking.    Patients who NIRS was used on during the 5 months of data 
tracking ranged from 24 weeks to 36 weeks with 10 of 15 patients monitored less than 27 weeks 
gestation.  Cerebral and Renal monitoring was used in 13 of 15 patients and renal monitoring 
only in 2 of 15 patients.  Patients were monitored from 1 day to 15 days with one patient actively 
being monitored at the time data tracking was completed.   
Discussion 
 The QI project did result in a statistically significant improvement in the providers 
comfort and understanding using, interpreting, and ordering NIRS on NICU patients as measured 
by the pre/post survey results.  These findings, however, should factor in that they survey was 
purposefully created for this project and does not have an established Cronbach’s alpha 
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coefficient for validation.  The survey questions were designed to assess the providers on topics 
related to NIRS use and interpretation and reviewed by the primary investigator and DNP 
mentor.  The post education survey was given 1 month after the teaching session in order to 
allow the providers time to review the material covered and use the NIRS on patients they felt 
could be monitored.  Of far greater importance than the statistical significance was the change in 
clinical practice with 15 patients monitored with NIRS during the 5 months of data tracking, an 
increase from 1 patient monitored in the previous year.  Additionally the patient population being 
monitored was a significant shift from historical use in the Northwestern NICU with 10 of 15 
patients being less 27 weeks or less gestation.  Previously only term infants with mature skin 
were monitored and now the use of Mepitel skin barrier product between the sensor and the 
infant’s skin.  The Mepitel barrier has helped alleviate some of the concern from providers 
regarding how tacky the sensors are when using them on preterm infants with fragile skin 
(McNeil, Gatenby, McElroy, & Engelhardt, 2010).   
 Though specific diagnoses were not tracked on patients who NIRS was ordered on, the 
investigator did notice three particular patient groups that were being monitored.  This was based 
on interactions with the ordering providers as well as the questions being asked about patient 
conditions and NIRS probe site selection.  The three groups were patients who were being 
observed for the presence of a hemodynamically significant PDA (hPDA), patients nearing red 
blood cell (RBC) transfusion criteria established by the unit specific transfusion algorithm, and 
preterm infants during the initial transition to extrauterine life.  These are three groups that are 
found in the current literature and in NIRS clinical trials.  Chock, Rose, Mante, and Punn (2016) 
published their findings related to the use of NIRS to monitor an infant for hPDA and cited a 
81% sensitivity and 77% specificity for infants with hPDA when the infants rSO2 was less than 
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66%.  This is valuable to the clinical setting as pediatric echocardiograms are a costly 
intervention not available at all hospital settings, however, clinical judgments on treating a hPDA 
should not be made on the rSO2 NIRS alone.  The SafeBoosc clinical guideline by Plomgaard et 
al. (2016) discusses different interventions for when cerebral NIRS values are less than the 
expected range and this was given to the medical staff during the educational teaching session.  
One of the interventions discussed was examining a patient’s hematocrit and considering a RBC 
transfusion if the values were consistently lower than expected (Plomgaard et al., 2016).  The 
improvement in the cRSO2 values when noted by the providers was often discussed with the 
investigator when reviewing the patient’s time with NIRS in place. 
 Prospectively, only time will tell if the increased utilization of NIRS in the Northwestern 
NICU will continue or if it was a direct result of the QI project and support being provided to the 
medical providers.  The NICU has a history of increased utilization of NIRS monitoring 
following educational presentations, however, their utilization decreased overtime.  Lewin’s 
Change Theory was chosen with the hopes of being able to change the clinical practice and then 
refreeze it into place.  Additional educational “check in’s” may help the providers with questions 
and allow for further discussion on the current research on NIRS use in NICUs, helping to 
sustain the change long term (Silver et al., 2016). The health information technology (HIT) 
department working within the NICU is currently working with the electronic medical record 
(EMR) to have data flow directly from the NIRS monitor into the patients record, eliminating the 
bedside nurses from having to enter the values hourly.  This advance with aid in decreasing data 
being missed and allow the providers to see remotely what the min to min graphically 
representation of NIRS data looks like.  This will decrease the frequency in which providers will 
have to come to the patient’s bedside to review the NIRS trends.   
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Limitations 
 The limitations of this QI project include its single site design with a provider group that 
had previous history using the NIRS monitors.  The survey used to assess for change in the 
providers comfort and confidence was designed specifically for this project and does not have a 
Cronbach’s alpha coefficient to report for validity of the survey findings.  Lastly the investigator 
does work in the NICU as a bedside RN and was responsible for providing care to some of the 
patients being monitored with NIRS, however, while working as the bedside RN refrained from 
suggesting or discussing NIRS monitoring on other patients with the providers unless asked by 
the provider specifically, as to prevent creating bias in the frequency of NIRS orders.   
Conclusion 
 This QI project focused on educating the providers on the current evidence and research 
into NIRS use on NICU patients while also supporting the clinicians when managing patients 
with NIRS monitoring in place.  The Northwestern US NICU had already invested capital budget 
into the purchase of three NIRS monitors, however, was not utilizing them for their patients.  
The educational session provided did show a significant change in the providers comfort and 
confidence on NIRS and a significant increase in the clinical utilization of NIRS monitoring was 
noted.  This project highlighted how revising previously abandoned clinical tools and monitors 
with new evidence can change provider practice, a very good reason for providers to attend 
continuing education seminars and conferences.  Just as Kenosi, Naulaers, Ryan, and Dempsey 
(2014) titled their article, the future looks brighter for cerebral oxygenation monitoring in 
preterm infants. 
Dissemination of Project Plan 
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 The project results were presented in poster format at ASU to DNP nursing faculty and 
students.  Completed DNP project poster was shared with the Northwestern NICU department 
staff with a review of the project results.  There is no further presentation or publication plan at 
this time.   
 Moving forward, alerts have been set for NIRS and NICU on PubMed, Cochrane Library, 
and CINAHL in order to keep abreast of the new research published on NIRS use.   The 
publications will be reviewed and additional teaching sessions 
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Evaluation Table 
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Conceptual 
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Design/ 
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Findings/ 
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Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Alderliesten, 
Dix, 2015, 
Reference 
values of 
rScO2 during 
first 3 days of 
life in preterm 
neonates. 
 
Country: The 
Netherlands 
Wilhelmina 
Children's 
Hospital Level 
III NICU 
 
Funding: 
Fellowship 
from RFF, 
ERC 
 
COI- None 
disclosed 
Physiologic 
Framework 
 
Quantitative 
 
Observational 
cohort Study 
 
Purpose: 
Establish rScO2 
reference 
values/tables for 
preterm infants 
for first 3 days of 
life 
n= 999 preterm 
infants (M 539 / 
F 460) 
GA <32 weeks 
Mean 28.7 SD 
1.96 
IC - born < 32 
weeks with PC 
between 1/2005 - 
9/2013 
EC - CM/SGA or 
severe congenital 
malformations, 
missing data sets 
DD - BW, 
APGAR score, 
hsPDA, presence 
of IVH, Mortality 
Variable of 
interest: rScO2 
over time 
Measured for 
first 72 hrs 
after birth  
INVOS 4100 or 
5100 with small 
adult electrode 
Data collected 
from birth through 
first 72 hrs.  
Sensor on 
forehead with 
elastic bandage.  
Mean value for 1 
hr periods were 
analyzed.  Small 
sample (n=16) 
with neonatal 
sensor for 
conversion data 
Linear, squared, 
and polinominal 
models to find 
best fit for both 
rScO2 and 
cFTOE. 
Creation of 
reference curves 
for GA in 2 week 
increments for 
both rScO2 and 
cFTOE for first 
72 hr of life 
 
Similar results to 
other similar 
studies for 
reference ranges 
Level IV 
 
Strength: Large 
sample size, 
establish, similar 
results to other 
studies 
 
Weakness: Use 
of adult sensor, 
only <32 week 
infants 
 
Highly 
applicable to 
practice, 
education on 
normal expected 
ranges for given 
GA and time. 
 
Conclusion: 
Good references 
for use of NIRS 
in practice on 
preterm infants 
through 
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transition 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Bozzetti 
(2016), rScO2 
and rSmO2 in 
IGUR preterm 
infants 
 
Country: Italy, 
San Gerardo 
Hospital 
 
Funding: None 
 
COI: None 
stated 
Physiologic 
Framework 
Quantitative 
 
Prospective 
Case-control 
Study 
 
Purpose: 
Examine BS in 
IGUR infants by 
measuring 
regional 
saturations 
n=20, 10 IUGR 
preterm infants 
10 AGA preterm 
infants (GA 29-
33 weeks) 
 
DD: GA, Gender, 
BW, APGAR, 
Prenatal steroids, 
hsPDA, IVH 
(BW only 
significant 
difference 
between groups 
(p=0.05) 
 
EC: CM/SGA, 
Perinatal 
asphyxia with 
multi-organ 
failure, skin 
disease at probe 
site  
IV1- rScO2 for 
IUGR infants 
IV2- rSmO2 
for IUGR 
infants 
IV3- rScO2 for 
non-IUGR 
infants 
IV4- rSmO2 
for non-IUGR 
infants  
DV1- T0 (12.3 
hr ±4.4 hr) 
DV2- T1 (62.7 
hr ± 4.0 hr) 
NIRS data from 
INVOS 5100 
placed infra-
umbilical and 
forehead.  
Measured in first 
24 hrs and again at 
48-72 hrs 
Student's t-test 
for continuous 
variables, Man-
Whitney U two 
sided, Kuskal-
Wallis, and 
fisher's exact / 
chi-squared 
CSOR of IV1 
and IV2 at DV1 
(p<0.001) 
 
IV1 > at DV1 
than DV2 
(p<0.001) 
 
cFTOE for IV1 
at DV1 and DV2 
(p<0.001), no 
difference in 
mFTOE (p not 
reported) 
 
CSOR for IV3 
and IV4 at DV1 
and DV2 
(p<0.001) 
 
IV2 and IV4 at 
DV1 and DV2 
(p<0.001) for 
both rSmO2 and 
mFTOE 
Level of 
evidence: Level 4 
 
Strengths: 
preselected 
infants for study 
based on 
ultrasound data.  
Two paired 
groups reflective 
of population 
difference in 
question 
 
Weakness: Small 
sample size and 
limited 
timeframe of 
measurement 
 
Application to 
practice: Good 
for monitoring 
differences in 
IUGR patients 
blood flow 
patterns to not 
push feeds to 
quickly post birth 
 
Conclusion: 
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Helps establish 
awareness of 
continued BS 
post birth and 
feeding 
considerations 
with continued 
BS effect 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
interventions 
studied 
Measurement/ 
Instrumentation 
Discussion 
of case 
studies 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Cerbo (2012). 
rScO2 and 
rSmO2 in sick 
preterm infants 
 
Country: Italy, 
Fondazione 
IRCCS, San 
Matteo 
 
Funding: No 
funding stated 
 
COI: No 
conflict of 
interest stated 
Physiologic 
framework 
Quantitative 
 
Case review of 3 
preterm infants 
and use of NIRS 
monitoring 
 
Purpose: review 
of use of NIRS in 
clinical practice 
with different 
patient diagnosis 
n= 3 
GA #1= 24 week 
M infant 
GA #2= 28 week 
F infant 
GA #3= 30 week 
M infant 
DD: HR, BP, 
pulse ox, rScO2 
and rSmO2 
Single center 
findings 
Variables: 
rScO2 and 
rSmO2 
 
Treatments: 
PDA ligation, 
UVC 
extravasations 
monitoring 
NIRS 
measurement of 
rScO2 and rSmO2 
with INVOS 5100 
Case #1: 
Preterm infant 
noted to have 
CSOR 
difference 
suggestive of 
PDA, required 
ligation 
Case #2: 
Preterm infant 
with atrial 
tachyarrhythmia 
shown to have 
PDA requiring 
ligation 
Case #3: Infant 
with UVC 
infiltrate noted 
with change in 
rSmO2 
Discussion of 
NIRS data 
findings prior to, 
during, and after 
PDA ligation 
with overall 
increase in rScO2 
noted when duct 
was closed 
NIRS data 
trended to show 
worsening 
hsPDA and 
changes during 
surgical closure 
Discussion of 
rSmO2 response 
with abdominal 
infiltration of 
umbilical 
catheter 
Level of 
evidence: Level 
VI 
Strengths: Shows 
use of NIRS in 
different disease 
process 
 
Weakness: Small 
number of cases, 
not easily 
reproducible 
 
Application to 
practice: 
Additional ways 
NIRS can be 
used to monitor 
disease processes 
 
Conclusion: 
Limited 
generalizability 
to populations 
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without 
reproducibility of 
case study results 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Chock (2016) 
NIRS for 
Detection of 
hsPDA. 
 
Country: USA, 
Stanford 
University 
Medical center, 
Luciel Packard 
Children's 
Hospital 
 
Funding: no 
support 
 
COI - None 
stated 
 
  
Physiologic 
framework 
Quantitative 
 
Non a-priori 
retrospective 
study 
 
Purpose: 
Determine if 
NIRS monitoring 
can show the 
presence of 
hsPDA with 
confirmation by 
Cardiac Echo 
n= 47 (M 15 / F 
32) 
GA <29 weeks 
with NIRS 
monitoring 
between 9/2013-
8/2015, Normal 
routine 
monitoring of 
rScO2 and rSrO2 
done on patients 
of this GA 
 
DD - GA, BW, 
Race, PNA, use 
of vasopressors, 
MV 
IV- rScO2 and 
rSrO2 values 
measured at 6 
days of life 
 
DV- Presence 
of hsPDA by 
cardiac Echo 
NIRS monitoring 
of both rScO2 and 
rSrO2 with 
INVOS 5100 
Cardiac Echos 
performed on any 
suspected infant 
with hsPDA 
without influence 
of rScO2 or rSrO2 
data and read by 
Peds Cardiology 
without 
knowledge of any 
rScO2 or rSrO2 
data 
Fisher's exact 
test w/Freeman-
-Halton 
extension, 
Kruskal-Wallis 
for 
nonparametric 
with Bonferroni 
correction 
rSrO2 less an 
66% correlated 
with hsPDA 
(p=0.03), rScO2 
was not 
significantly 
different between 
confirmed 
hsPDA and non 
hsPDA (p=0.24), 
rScO2 to rSrO2 
ratio higher with 
hsPDA 
(p=0.007) 
Level IV 
 
Strength: 
Measured when 
hsPDA plays a 
physiologic role 
 
Weakness: Small 
sample size 
 
Applicable to 
clinical practice 
as a non invasive 
tool to monitor 
for hsPDA 
without added 
cost of Cardiac 
Echo 
 
Conclusion: 
Small study size, 
good consistent 
result when 
confirmed by 
Echo 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
NEAR-INFRARED SPECTROSCOPY NICU  32 
Key:  AGA – Appropriate for Gestational age, BP - Blood pressure, BPD - Bronchopulmonary displasia  BS – Brain sparring, BW - Birth weight, cFTOE - cerebral fractional tissue oxygen extraction, CM/SGA - Cardiac malformation 
or severe chromosomal abnormalities, COI - Conflicts of interest, CSOR – cerebral / splanchnic oxygenation ratio, DD - Demographic data, DV-dependent variable, EC - Exclusion criteria, EEG - Electroencephalographic,  ERC - 
European Research Council, F - Female, GA - Gestational Age, HR - Heart rate, hsPDA - hemodynamically significant patent ductus arteriosus, IC - Inclusion criteria, IUGR – Intrauterine Growth Restricted, IV- independent variable, 
IVH - Intraventricular hemorrhage, M - Male, mFTOE – Mesenteric fractional tissue oxygen extraction, MV - Mechanical ventilation, N-number of studies, n- number of participants, NEC - Necrotizing Enterocolitus,  NIH – National 
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practice/ 
application to 
practice 
Gillam-
Krakauer 
(2013). 
Correlation of 
rSmO2 with 
Superior 
mesenteric 
artery velocity 
 
Country: USA, 
Vanderbilt 
Children’s 
Hospital 
 
Funding: 
Grand from 
Vanderbilt 
Institute for 
clinical and 
translational 
research, 
unrestricted 
technology 
grant from 
Somanetics, 
NIH grant 
 
COI: 
Unrestricted 
Somanetics 
grant 
Physiologic 
framework 
Quantitative 
 
Prospective 
Observational 
single-center trial 
 
Purpose: 
Determine if 
variations in 
rSmO2 measured 
by NIRS 
correlated with 
measured 
variations in 
superior 
mesenteric artery 
velocities. 
n=18 (M 9, F 9) 
GA: 25 – 31 
weeks 
Attrition: 28% 
(18/25) 
 
IC: GA 23 6/7 to 
30 6/7 weeks, < 
1500 g, < 14 days 
of age, tolerating 
enteral feeds 10-
20 ml/kg/day 
 
EC: CM/SGA, 
IUGR, 
Gastrointestinal 
anomalies, 
pressor support 
within 24 hrs, 
severe jaundice, 
hx necrotizing 
enterocolitis 
 
DD: GA, BW, 
Gender, Race, 
APGAR, PNA, 
Days to full feeds 
rSmO2 data 
and the 
corresponding 
superior 
mesenteric 
artery velocity 
in three 
intervals 
around feeding 
for three 
consecutive 
days  
 
Higher superior 
mesenteric 
artery velocity 
would correlate 
with increased 
blood flow to 
the abdominal 
viscera 
rSmO2 with 
INVOS 5100 with 
neonatal sensor 
placed midline 
below the 
umbilicus, 
measured just 
prior to starting 
feeding, 10 mins 
after feeding, and 
60-120 mins after 
feeding 
completed. 
 
Doppler 
ultrasound of 
SMAV (systolic, 
diastolic and 
mean) by Siemans 
Acuson Sequoia 
measured just 
prior to starting 
feeding, 10 mins 
after feeding, and 
60-120 mins after 
feeding 
completed.  Total 
of 9 ultrasound 
measurements, 
around 3 different 
feedings 
 
Spearman’s 
rank 
correlation, 
Wilcoxon test, 
and Kruskal-
Wallis 
Kruskal-Wallis 
on rSmO2 and 
Dopplar flow 
measures were 
not significantly 
different from 
day 1 to day 3. 
Not significant in 
pre feeding or 
60-120 mins post 
feeding 
(p=0.068, 0.062, 
and 0.53 for 
systolic, 
diastolic, and 
mean pre 
feeding) 
Significant 
difference in 10 
mins post feed in 
all SMAV 
(p=0.013, 0.015, 
and 0.005) 
Level of 
evidence: 
 
Strengths:  
 
Weakness: Small 
sample size,  
 
Application to 
practice: Limited 
beyond 
continued focus 
on variability in 
NIRS data being 
more clinically 
important 
 
Conclusion: 
Provides jumping 
off point for 
further research 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
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practice/ 
application to 
practice 
Hyttel-
Sorensen 
(2015). rScO2 
in Phase II 
clinical trial 
 
Country: 8 
European 
countries 
(retrieved from 
British medical 
journal) 
 
Funding: 
Unrestricted 
grand from 
Danish 
Council for 
Strategic 
research 
 
COI: None 
stated 
 
Physiologic 
Framework 
Quantitative 
 
Phase II 
randomised, 
blinded, 
feasibility trial 
 
Randomization 
by computer 
generated 
allocation 
sequence 
 
Purpose: test the 
SafeBoosc 
recommendations 
for reduction in 
rScO2 burden in 
multiple centers 
n= 166 infants 
Intervention 
group: 86 (M 44, 
F 51) 
Control group: 80 
(M 34, F 43) 
DD: BW, GA, 
Sex, prenatal 
steriods, length 
(time) of rupture 
of membranes, 
presence of 
chorioamnionitis, 
APGAR, 
Umbilical artery 
pH 
IC: At least 12 
weeks preterm, 
establish rScO2 
within 3 hrs of 
birth with PC 
EC: Inability to 
place rScO2 
within 3 hrs, no 
NIRS monitor 
available, no PC, 
decision for no 
life support 
measures 
Power of 95% 
with sample size 
of 166 estimated 
Attrition: 4% 
(6/166) 
IV1- rScO2 
data visible to 
medical staff  
IV2- rScO2 not 
visible to 
medical staff 
DV- Cerebral 
oxygen burden 
(hypoxia or 
hyperoxia) 
NIRS data from 
INVOS 5100c 
with adult sensor 
measuring rScO2 
from 3 hrs through 
72 hrs after birth.  
INVOS were 
blinded by being 
placed in a box or 
in a research 
specific screen 
mode 
Specific 
statistical 
analysis tests 
were not 
discussed.  
Cited as 
utilizing two 
sided tests with 
P of 0.05 and 
mixed modeling 
for continuous 
variables and 
ordinary 
logistic 
regression for 
binary and 
ordinal 
outcomes 
IV1 to DV 
(p<0.001) when 
compared to IV2 
to DV, primary 
reduction in 
hypoxia 
 
DD were not 
significant 
between IV1 and 
IV2 
No secondary 
measures were 
significant 
between IV1 and 
IV2 
Level of 
evidence: Level 
II 
 
Strengths: Large 
multicenter RCT 
utilizing 
established 
interventional 
guidelines 
 
Weakness: First 
study of its kind 
with infants, no 
discussion of 
stats analyzed 
 
Application to 
practice: shows 
the importance of 
utilizing 
interventions to 
reduce rScO2 
oxygen debt 
when monitoring 
with NIRS 
 
Conclusion: 
Good evidence 
for the use of 
NIRS to reduce 
potential harmful 
oxygen debt and 
use of clinical 
treatement 
recomendations 
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from SafeBoosc 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Interventions 
used during 
RCT 
Measurement/ 
Instrumentation 
Impact on 
practice 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Pellicer 
(2013),  
SafeBoosC 
Phase II RCT 
treatment 
guideline 
 
Country: Spain 
(La Paz 
University 
Hospital) 
 
Funding: 
Danish 
Council for 
Strategic 
Research 
 
COI: None 
stated 
Physiologic 
Framework 
Quantitative 
 
Systematic 
Review 
 
Purpose: 
Describe the 
rational for the 
treatment 
guideline and the 
algorithm for the 
interventions per 
SafeBoosC 
N= 229 initial 
studies, 61 
directly relevant 
to treatment 
guideline and 9 
RCT's 
 
SafeBoosC is a 
randomized 
clinical trial 
involving 
premature infants 
from birth 
through the first 
72 hrs of life 
examining rScO2 
values measured 
by NIRS 
Cardiovascular 
status review 
 
Oxygen 
Transportation 
 
Respiratory 
Status 
 
Blood Glucose 
management 
Recommendations 
based on level of 
evidence from I to 
III with Level I 
being from RCT 
and Level III 
being opinions 
from respected 
authorities 
 
Recommendations 
based on quality 
of evidence from 
good to fair to 
poor and net 
benefit to health 
outcomes from 
substantial to 
zero/negative.   
 
MeSH terms 
searched through 
PubMed: Neonate, 
NIRS, 
cerebrovascular 
circulation, BP, 
hypotension, 
dopamine, 
dobutabmine, 
epinepherine, 
anesmia, blood 
Provides 
background for 
interventions 
recommended 
by SafeBoosC 
RCT 
All 
recommendations 
have at least a 
Level II study 
supporting and a 
minimum of 
small to 
substantial net 
benefit 
Level of 
evidence: Level I 
 
Strengths: 
Provided rational 
for clinical 
interventions 
 
Weakness: Some 
recommendations 
are only weakly 
supported by 
research 
 
Application to 
practice: Highly 
applicable if 
monitoring 
rScO2 in preterm 
infants 
 
Conclusion: 
Good for basis of 
interventions 
used to correct 
rScO2 outside of 
expected ranges 
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transfusion, CO2, 
RDS, PDA, and 
treatment 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Pichler, Binder 
(2013) 
Reference 
ranges for 
rScO2 and 
cFTOE during 
neonatal 
transition 
 
Country: 
Austria, Royal 
Alexandra 
Hospital 
 
Funding: 
Jubilaumfsond, 
Osterreichische 
National-Bank 
 
COI: No 
conflict stated 
Physiologic 
framework 
Quantitative 
 
Prospective 
Observational 
Study 
 
Purpose: 
determine range 
values for rScO2 
during neonatal 
transition using 
NIRS 
n= 381 neonates 
(82 Term vaginal 
delivered, 272 
term Cesarean 
delivered, 27 
preterm Cesarean 
delivered) 
DD: BW, GA, 
Apgars, SpO2, 
HR 
EC: Vacuum 
assisted or 
forceps assisted 
delivery, 
Respiratory 
support during 
transition 
 
Setting: Medical 
university of 
Graz between 
1/2009 - 8/2012 
 
Attrition: none, 
analysis done for 
only those who 
had complete data 
sets 
IV1- rScO2 
IV2- cFTOE  
DV- Time 
Birth through 
15 mins 
Invos 5100 
monitor with 
neonatal sensor 
placed on left 
frontoparietal 
forehead, secured 
with strap 
 
Measurements 
started at 2 mins 
of age and 
continued for 15 
mins during 
transition 
Least mean 
squares for 
rScO2 and 
cFTOE and 
linear mixed 
modeling with 
first order 
autoregressives 
covariance 
structure for 
ovarall effects 
and differenced 
between groups 
 
P value set to 
0.05 
Stats for HR and 
SpO2 differences 
min by min for 
three population 
groups 
rScO2 at 4 and 5 
mins for vag 
term deliveries 
was higher than 
Ceserean term (p 
= 0.003) 
 
Four rScO2 vs 
time graphs and 
four cFTOE vs 
time graphs 
 
Two tables with 
10th, 50th, and 
90th percentile 
for rScO2 and 
cFTOE 
Level of 
evidence: Level 
IV 
Strengths: Large 
sample size, 
Multiple 
gestations, 
Establish normal 
transition data set 
 
Weakness: 
Limited to 15 
mins of 
transition, 
minimal vaginal 
preterm infants,  
 
Application to 
practice: Assist 
with guiding 
normal transition 
in delivery room 
 
Conclusion: 
Helps establish 
base knowledge 
of use during 
transition and 
expected data 
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points/goals for 
normal transition 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Pichler (2016), 
rScO2 to guide 
oxygen 
delivery 2 
center RCPT 
 
Country: 
Austria, 
Medical 
University of 
Graz 
 
Funding: None 
stated 
 
COI: No 
conflicts stated 
Physiologic 
Framework 
Quantitative 
 
Multicenter 
Randomized 
controlled Pilot 
Feasibility trial 
 
Randomized by 
sealed envelope 
opened just 
before birth 
 
Neonatology 
staff in NICU 
was blinded to 
whether NIRS 
was visible to 
resuscitation 
team on delivery 
of infant 
Two sites: Graz, 
Austria and 
Edmonton, 
Alberta CA 
n= 60, 30 at each 
site, 15 in Control 
group and 15 in 
intervention 
group, (M - 32, F 
- 28) 
DD: GA, BW, 
APGAR, Sex, 
Mortality, IVH 
rates, NEC rates, 
ROP, BPD 
IC: PC, < 34 
weeks, choice to 
provide life 
support 
EC: Congenital 
malformation or 
no life support 
 
Attrition: 0/60 
IV 1-rScO2 
visible to 
resuscitation 
team 
IV 2 - rScO2 
not visible to 
resuscitation 
team 
DV- Oxygen 
debt defined as 
hypoxia or 
hyperoxia 
during 
resuscitation as 
measured by  
cerebral NIRS 
IVOS 5100 with 
cerebral monitor 
placed on Left 
forehead and 
covered with hat.  
Continuous data 
was recorded and 
means for each 
min were 
calculated for HR, 
Saturation, and 
rScO2.  Delayed 
cord clamping was 
done between 30 
to 60 seconds for 
eligible infants.   
 
Data was collected 
for the first 15 
mins after birth 
Chi Squared, 
Fisher exact test 
for discrete 
variables, t test 
or Mann-
WhitneyU for 
continuous 
variables. 
 
Group 
differences with 
Mann-Whitney 
U 
 
Mean values 
expressed in 
models and 
P<.05 for 
statistical 
significance 
No significant 
DD differences 
 
IV1 vs IV2 on 
DV Reduction in 
cerebral oxygen 
debt (p=.028) for 
patients who had 
complete data 
sets available for 
analysis 
 
IV1 vs IV2 on 
DV for all 
patients not 
significant 
(p=.107) 
 
Teams with 
visible NIRS 
were able to 
add/wean resp 
support reducing 
cerebral hypoxia 
quicker 
Level of 
evidence: Level 
II 
 
Strengths: 
Showed 
reduction in 
oxygen debt 
during 
resuscitation, 
multiple centers 
 
Weakness: Small 
sample size, Not 
significant result 
on whole of data 
set 
 
Application to 
practice: Could 
help guide 
resuscitation of 
known NICU 
admits 
 
Conclusion: 
Good application 
of NIRS similar 
to SafeBoosC 
clinical trial 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Plomgaard 
(2016) 
SafeBoosC II 
RCT: 
treatment 
guided by 
NIRS reduces 
cerebral 
hypoxia 
 
Country: 6 
European 
countries 
(retreieved 
from Pediatric 
RESEARCH) 
 
Funding: 
Danish 
Council for 
Strategic 
Research 
 
COI: No 
authors cite 
conflicts 
Physiologic 
framework 
Quantitative 
 
Extension of 
original RCT 
 
Purpose: Extend 
the findings of 
initial RCT to 
examine the 
effect on cerebral 
hypoxia by EEG 
n= 158 in RCT, 
133 for analysis 
in subgroup of 
EEG recording, 
123 for blood 
biomarker 
analysis 
 
DD: BW, GA, 
Twin delivery, 
APGAR, 
Antinatal 
steriods,  
 
Setting: NICU in 
6 different 
European 
countries 
 
 
 
Attrition: 16/158 
(10%), 8 died 
before 64 hr 
mark, 8 did not 
have EEG 
IV1- NIRS 
visible 
IV2- Control 
group without 
NIRS 
DV1- EEG 
DV2- Blood 
Biomarker 
EEG at 64 hrs of 
age by amplitude-
integrated EEG at 
P3 and P4 
locations with 120 
mins of recording 
time 
 
Blood biomarkers 
at 6 hrs and 64 
hrs, 1 ml per 
collection, 
markers S100β, 
BFABP, and 
Neuroketal 
examined 
EEG examined 
for normality, 
multiple 
regression 
modeling of 
estimated 
means 
 
Biomarkers 
with 
logarithmic 
transformation, 
linear mixed 
modeling 
analysis and 
unstructured 
covariance 
matrix.  Mann 
Whittney U for 
non normal 
distributed data 
No significant 
changes noted 
between IV1and 
IV2 on DV1 or 
DV2 
 
The use of 
cerebral NIRS 
did not have an 
effect on the 
EEG or blood 
biomarkers for 
cerebral damage 
Level of 
evidence: Level 
II 
 
Strengths: Data 
found during 
RCT, well 
designed 
multicenter trial, 
multiple data 
variables 
analyzed 
 
Weakness: EEG 
and biomarkers 
are not 
established 
markers for brain 
injury 
 
Application to 
practice: 
Additional 
justification for 
use of clinical 
guideline 
 
Conclusion: The 
SafeBoosC 
treatment 
guideline did not 
have a negative 
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effect on EEG of 
preterm infants 
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Appendix E 
Synthesis Table 
 Alderliesten Bozzetti Cerbo Chock Gillam-
Krakauer 
Hyttel-
Sorensen 
Pellicer Pichler, 
Binder 
Pichler Plomgaard 
Year 2015 2016 2012 2016 2013 2015 2013 2013 2016 2016 
RCT      X   X X (Extension) 
NPRS    X       
POT     X      
SR       X    
OCS X          
POS        X   
PCCS  X         
CS   X        
N 999 20 3 47 18 166  381 60 158 
Ns       229    
Demographics           
GA range, (Mn) 24-31 (28.7) 29-33 (31 1/7)  25-28 25-31 (28) 25-27 (26)  34-40 (29.5) (24.4-27.6) 
BW range, (Mn) 0.770-1.375 1.157  0.66-1.038 (1.203) 0.410-1.33  2.259-
3.386 
(1.35) 0.41-1.33 
Mn APGAR at 1,5 mins 7, 8 -, 9   7,8   9, 10 6, 8  
Setting           
NICU X X X  X X  X X X X X 
United States    X X      
Spain       X    
Europe      X (8 
countries) 
   X (6 countries) 
Austria        X X  
Italy  X X        
Netherlands X          
Findings           
Creation of reference ranges X X      X   
Reduction in oxygen debt      X   X  
No negative impact to infant          X 
Able to monitor for hsPDA   X X       
Physiologic response     ↓ post feed      
           
Measurement Interval           
Birth - Transition        X X  
Birth - 72 hrs X     X X   X 
Measurement device           
Invos used X X X X X X  X X X 
Independent variables           
rScO2 X X X X  X  X X X 
rSrO2    X       
rSmO2  X X  X      
cFTOE        X   
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NICU- neonatal intensive care unit, OCS- Observational cohort study, RCT - Randomized controlled trial, PCCS - Prospective case-control study, POT - Prospective Observational Trial, POS - Prospective Observational Study, R- 
range, rScO2 - regional cereberal oxygen saturation, rSmO2 - regional mesenteric oxygen saturation, rSrO2 - regional renal oxygen saturation, SMAV - Superior mesenteric artery velocity, SR- systematic review 
 Alderliesten Bozzetti Cerbo Chock Gillam-
Krakauer 
Hyttel-
Sorensen 
Pellicer Pichler, 
Binder 
Pichler Plomgaard 
Independent variables 
Cont. 
          
IUGR  X         
Non-IUGR  X         
Dependent variables           
Oxygen Debt      X   X  
hsPDA presence    X       
SMAV     X      
Time (post birth) X X      X   
EEG variance          X 
Blood Biomarkers          X 
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Appendix F 
Rosswurn and Larrabee EBP model 
 
 
 
Figure 1. From Rosswurm, M. & Larrabee, J. (1999). A model for change to Evidence-Based   
 practice.  Journal of Nursing Scholarship.31:4, 317-322. 
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Appendix G 
Survey to assess Provider Comfort and Confidence 
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